103 related articles for article (PubMed ID: 11759188)
1. The role of subareolar blue dye in identifying the sentinel node in patients with invasive breast cancer.
Mokbel K; Mostafa A
Curr Med Res Opin; 2001; 17(2):93-5. PubMed ID: 11759188
[No Abstract] [Full Text] [Related]
2. Efficacy of methylene blue dye in localization of sentinel lymph node in breast cancer patients.
Nour A
Breast J; 2004; 10(5):388-91. PubMed ID: 15327490
[TBL] [Abstract][Full Text] [Related]
3. Concordance of peritumoral technetium 99m colloid and subareolar blue dye injection in breast cancer sentinel lymph node biopsy.
Kargozaran H; Shah M; Li Y; Beckett L; Gandour-Edwards R; Schneider PD; Khatri VP
J Surg Res; 2007 Nov; 143(1):126-9. PubMed ID: 17950081
[TBL] [Abstract][Full Text] [Related]
4. Methylene blue dye--a safe and effective alternative for sentinel lymph node localization.
Varghese P; Abdel-Rahman AT; Akberali S; Mostafa A; Gattuso JM; Carpenter R
Breast J; 2008; 14(1):61-7. PubMed ID: 18186867
[TBL] [Abstract][Full Text] [Related]
5. Sentinel lymph node mapping of breast cancer: a case-control study of methylene blue tracer compared to isosulfan blue.
Eldrageely K; Vargas MP; Khalkhali I; Venegas R; Burla M; Gonzalez KD; Vargas HI
Am Surg; 2004 Oct; 70(10):872-5. PubMed ID: 15529840
[TBL] [Abstract][Full Text] [Related]
6. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
7. Double mapping with subareolar blue dye and peritumoral green dye injections decreases the false-negative rate of dye-only sentinel node biopsy for early breast cancer: 2-site injection is more accurate than 1-site injection.
Anan K; Mitsuyama S; Kuga H; Saimura M; Tanabe Y; Suehara N; Matsunaga H; Nishihara K; Abe Y; Iwashita T; Ihara T; Tamae K; Ono M; Toyoshima S
Surgery; 2006 May; 139(5):624-9. PubMed ID: 16701094
[TBL] [Abstract][Full Text] [Related]
8. Added value of blue dye in sentinel node biopsy for breast cancer.
Snoj M; Golouh R; Movrin-Stanovnik T; Vidergar-Kralj B
J Exp Clin Cancer Res; 2003 Dec; 22(4):551-5. PubMed ID: 15053296
[TBL] [Abstract][Full Text] [Related]
9. [Efficiency of lymphatic mapping by intradermal injection of vital blue dye for sentinel node identification in T1-2 N0-1 M0 stage breast cancer patients].
Kokhreidze I; Nemsadze G; Gersamia G; Dzagnidze G; Janjalia M
Georgian Med News; 2005 Apr; (121):7-10. PubMed ID: 15908713
[TBL] [Abstract][Full Text] [Related]
10. Blue-dye intraoperative sentinel lymph node mapping in early non-small cell lung cancer.
Rzyman W; Hagen OM; Dziadziuszko R; Kobierska-Gulida G; Karmolinski A; Lothe MI; Paleczka W; Murawski M; Jastrzebski T; Kopacz A; Jassem J; Skokowski J
Eur J Surg Oncol; 2006 May; 32(4):462-5. PubMed ID: 16504458
[TBL] [Abstract][Full Text] [Related]
11. Validation of subareolar and periareolar injection techniques for breast sentinel lymph node biopsy.
Chagpar A; Martin RC; Chao C; Wong SL; Edwards MJ; Tuttle T; McMasters KM
Arch Surg; 2004 Jun; 139(6):614-8; discussion 618-20. PubMed ID: 15197087
[TBL] [Abstract][Full Text] [Related]
12. Safety and technical success of methylene blue dye for lymphatic mapping in breast cancer.
Zakaria S; Hoskin TL; Degnim AC
Am J Surg; 2008 Aug; 196(2):228-33. PubMed ID: 18367146
[TBL] [Abstract][Full Text] [Related]
13. Can methylene blue only be used in sentinel lymph node biopsy for breast cancer?
Golshan M; Nakhlis F
Breast J; 2006; 12(5):428-30. PubMed ID: 16958960
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the adverse reactions associated with isosulfan blue versus methylene blue dye in sentinel lymph node biopsy for breast cancer.
Thevarajah S; Huston TL; Simmons RM
Am J Surg; 2005 Feb; 189(2):236-9. PubMed ID: 15720998
[TBL] [Abstract][Full Text] [Related]
15. Blue-dye technique complements four-node sampling for early breast cancer.
Ishikawa T; Momiyama N; Hamaguchi Y; Tanabe M; Tomita S; Ichikawa Y; Nakatani Y; Sasaki T; Nozawa A; Inayama Y; Inui K; Shimada H
Eur J Surg Oncol; 2005 Dec; 31(10):1119-24. PubMed ID: 16005597
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the adverse reactions associated with isosulfan blue versus methylene blue dye in sentinel lymph node biopsy for breast cancer.
Aydogan F; Celik V; Uras C; Salihoglu Z; Topuz U
Am J Surg; 2008 Feb; 195(2):277-8. PubMed ID: 18194680
[No Abstract] [Full Text] [Related]
17. Sentinel lymph node biopsy in management of early breast cancer: Is it rational to omit blue dye injection?
Kaviani A; Noveiry BB; Noaparast M
Surgery; 2012 Jul; 152(1):140. PubMed ID: 22386708
[No Abstract] [Full Text] [Related]
18. Intraoperative methylene blue sentinel lymph node mapping in colorectal cancer.
Chan SH; Ng C; Looi LM
ANZ J Surg; 2008 Sep; 78(9):775-9. PubMed ID: 18844907
[TBL] [Abstract][Full Text] [Related]
19. Intradermal radioisotope is superior to peritumoral blue dye or radioisotope in identifying breast cancer sentinel nodes.
Lin KM; Patel TH; Ray A; Ota M; Jacobs L; Kuvshinoff B; Chung M; Watson M; Ota DM
J Am Coll Surg; 2004 Oct; 199(4):561-6. PubMed ID: 15454139
[TBL] [Abstract][Full Text] [Related]
20. [Sentinel nodes identification efficacy prognostic criteria in breast cancer].
Kokhreidze ID; Nemsadze GG; Gersamiia GK; Dzagnidze GB; Dzhandzhaliia MT
Georgian Med News; 2005 Feb; (119):31-4. PubMed ID: 15834176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
